Emerging phototherapy in a clinic as well as plant photomorphogenesis call for efficient red/far-red light resources to target and/or actuate the interaction of light and living organisms. Rare-earth doped phosphors are generally promising candidates for efficient light-emitting diodes but still bear lower quantum yield for the far-red components, potential supply risks, and high cost issues. Thus, design and preparation of efficient non-rare-earth activated phosphors becomes extremely important and arouses great interest. Fabrication of Cr3+-doped Na3AlF6 phosphors significantly promotes the potential applications by efficiently converting blue excitation light of a commercial InGaN chip to far-red broadband emission in the 640-850 nm region. Action response of phototherapy (~ 667-683 nm; ~ 750-772 nm) and that of photomorphogenesis (~ 700-760 nm) are well overlapped. Based on the temperature-dependent steady luminescence and time-resolved spectroscopies, energy transfer models are rationally established by means of the configurational coordinate diagram of Cr3+ ions. An optimal sample of Na3AlF6: 60% Cr3+ phosphor generates a notable QY of 75 ± 5%. Additionally, an InGaN LED device encapsulated using Na3AlF6: 60% Cr3+ phosphor was fabricated. The current exploration will pave a promising way to engineer non-rare-earth activated optoelectronic devices for all kinds of photobiological applications.
A general overview of the trends in structural and thermodynamic properties that have been identified within the hydrated normal rare earth carbonates and the rare earth hydroxycarbonates is presented. Based upon available literature, we demonstrate the trends in crystallographic unit cell parameters, thermal stability, aqueous solubility, and thermochemical properties. These trends can be attributed to both the unique chemistry and strong similarity of the rare earth elements. There are also inconsistent trends that signal research needs to better understand the structure–energy relationships of the rare earth carbonates.
1 April 2019 in The Journal of Chemical Thermodynamics
As the field of nanotechnology continues to grow, evaluating the cytotoxicity of nanoparticles is important in furthering their application within biomedicine. Here, we report the synthesis, characterization, and cytotoxicity of nanoparticles of different morphologies of yttrium oxide, a promising material for biological imaging applications. Nanoparticles of spherical, rod-like, and platelet morphologies were synthesized via solvothermal and hydrothermal methods and characterized by transmission electron microscopy (TEM), X-ray diffraction (XRD), light scattering, surface area analysis, thermogravimetric analysis (TGA), and zeta potential measurements. Nanoparticles were then tested for cytotoxicity with human foreskin fibroblast (HFF) cells, with the goal of elucidating nanoparticle characteristics that influence cytotoxicity. Cellular response was different for the different morphologies, with spherical particles exhibiting no cytotoxicity to HFF cells, rod-like particles increasing cell proliferation, and platelet particles markedly cytotoxic. However, due to differences in the nanoparticle chemistry as determined through the characterization techniques, it is difficult to attribute the cytotoxicity responses to the particle morphology. Rather, the cytotoxicity of the platelet sample appears due to the stabilizing ligand, oleylamine, which was present at higher levels in this sample. This study demonstrates the importance of nanoparticle chemistry on in vitro cytotoxicity, and highlights the general importance of thorough nanoparticle characterization as a prerequisite to understanding nanoparticle cytotoxicity.
Realizing the promise of precision medicine in cancer therapy depends on identifying and tracking cancerous growths to maximize treatment options and improve patient outcomes. This goal of early detection remains unfulfilled by current clinical imaging techniques that fail to detect lesions due to their small size and suborgan localization. With proper probes, optical imaging techniques can overcome this by identifying the molecular phenotype of tumors at both macroscopic and microscopic scales. In this study, the first use of nanophotonic short wave infrared technology is proposed to molecularly phenotype small lesions for more sensitive detection. Here, human serum albumin encapsulated rare‐earth nanoparticles (ReANCs) with ligands for targeted lesion imaging are designed. AMD3100, an antagonist to CXCR4 (a classic marker of cancer metastasis) is adsorbed onto ReANCs to form functionalized ReANCs (fReANCs). fReANCs are able to preferentially accumulate in receptor positive lesions when injected intraperitoneally in a subcutaneous tumor model. fReANCs can also target subtissue microlesions at a maximum depth of 10.5 mm in a lung metastatic model of breast cancer. Internal lesions identified with fReANCs are 2.25 times smaller than those detected with ReANCs. Thus, an integrated nanoprobe detection platform is presented, which allows target‐specific identification of subtissue cancerous lesions.